Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Shanghai Sunway Biotech Co. Ltd.
Headquarters:
Shanghai, China
Website:
http://www.sunwaybio.com.cn
Year Founded:
1995
Status:
Private
BioCentury
|
Sep 6, 2024
Distillery Therapeutics
Engineered oncolytic virus for activation of bystander antiviral T cells in cancer
Read More
BioCentury
|
Nov 18, 2022
Product Development
Oncolytic virus combinations move beyond checkpoint inhibitors
SITC updates suggest the next wave of oncolytic viruses will be paired with bispecifics, cell therapies
Read More
BioCentury
|
Nov 16, 2021
Data Byte
The oncolytic virus pipeline
At least 49 oncolytic virus therapies now in development behind the sole FDA-approved product
Read More
BioCentury
|
Sep 15, 2017
Company News
China Resources invests in Converd
Read More
BioCentury
|
Sep 13, 2017
Company News
China Resources invests in Converd
Read More
BioCentury
|
Feb 29, 2016
Product Development
Infectious enthusiasm
How oncolytic viruses are coming of age in cancer immunotherapy combinations
Read More
BioCentury
|
Jan 31, 2011
Strategy
Lysing what it sees
Amgen buying BioVex for OncoVEX immunotherapy based on Phase II melanoma data
Read More
BioCentury
|
Feb 8, 2010
Product Development
Checking the boxes in gene therapy
Read More
BioCentury
|
May 14, 2009
Distillery Therapeutics
Indication: Cancer
Read More
BioCentury
|
Sep 18, 2008
Cover Story
Dismantling cancer's immune defense
Read More
Items per page:
10
1 - 10 of 12